Roche (RHHBY) is upgraded to Buy as strong 2025 growth, new drug launches, and obesity drug potential create an attractive ...

The full size recreation of the ZX Spectrum has been so popular for Black Friday it's sold out – but not everywhere ...

Discover why Montrose Environmental Group (MEG) is rated a Buy, with strong earnings, growth potential, and undervalued ...

SME IPOs can offer gains, but they will not build your future. A market trend that moves on hype needs clarity, not rush.

Fluor Corporation owns nearly 40% of SMR nuclear company NuScale Power Corporation. From one perspective, nuclear power plant ...

While Robinhood Markets, Inc. (NASDAQ:HOOD) shareholders have had a good week with the stock up 20%, they shouldn't let their guards down. Although prices were relatively low, insiders chose to sell ...

Learn more about whether Ultragenyx Pharmaceutical Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether Arcus Biosciences, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

If the company is forced to offload even 100,000 of its 649,870 coins to meet obligations, it could trigger a systemic ...

Stocks got a lift from rising hopes that the Federal Reserve will cut its main interest rate again at its next meeting in ...

HSBC’s share price is near an all-time high, but this doesn’t mean a lack of value left in the stock. Simon Watkins believes ...